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Objective: This study investigated the pregnancy outcomes of women who had undergone kidney
transplantations from 1992 to 2013 in a single medical center.
Materials and Methods: Records for patients who had undergone kidney transplantations between 1992
and 2013 at National Taiwan University Hospital, Taipei, Taiwan were retrospectively reviewed, and data
on obstetric conditions, neonatal outcomes, and maternal and neonatal complications were collected.
Results: Data for a total of 15 pregnancies in 13 women who had undergone kidney transplantation
between 1992 and 2013 were included in this study. The live birth rate was 87%. The mean gestational
age was 35.4 ± 3.2 weeks, and the mean birth body weight was 2208.8 ± 678.8 g. Forty percent of the
neonates were small for their gestational age (< 10th percentile); 53.3% of the pregnancies resulted in
preterm deliveries (< 37 weeks); and 26.7% of the neonates needed Neonatal Intensive Care Unit
admission. The prevalence rates of preeclampsia and gestational diabetes were 23.0% and 13.3%,
respectively.
Conclusion: The pregnancy outcomes after kidney transplantation were favorable and the mean birth
body weight was 2208.8 ± 678.8 g at 35.4 ± 3.2 weeks gestational age. However, the maternal and
neonatal complication rates were still high, such as preterm labor, preeclampsia, and small for gesta-
tional age.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
There are more than 500 kidney transplantations performed in
Taiwan each year [1] and Taiwan has the highest rate of end-stage
renal disease (ESRD) and dialysis rate in the world [2]. Pregnancy is
uncommon in women with ESRD on chronic dialysis [3]. Kidney
transplant recipients appear to have a better pregnancy rate and
live birth rate. Physiologically, hypothalamic gonadal function [4]
and ovulation functions [5] in females with ESRD normalized
mostly after kidney transplantation. In a previous study, Gill et al
[6] reported that the unadjusted pregnancy rate was 3.3% in the
United States during the ﬁrst three posttransplant years. Various
studies on renal allograft recipients have reported successful
pregnancy outcomes [7e9]. In a meta-analytical study, Deshpandes and Gynecology, National
rsity College of Medicine, 100
bstetrics & Gynecology. Publishedet al [10] reported the overall post kidney transplantation live birth
rate and miscarriage rate to be 73.5% and 14.0%, respectively.
However, kidney transplant recipients might have a higher risk of
both maternal and neonatal complications, such as preeclampsia,
gestational diabetes, preterm labor, and small for gestational age
[11].
Premature birth (< 37 weeks) and low birth weight (< 2500 g)
were among the most common neonatal complications, affecting
nearly half of all newborns. Fortunately, newborn and maternal
outcomes seem to remain favorable with successive pregnancies
[12]. Improved prepregnancy renal function is also associated with
superior graft outcomes [13]. Patients with a prepregnancy creati-
nine > 150 mmol/L (1.7 mg/dL) are more likely to encounter renal
function deterioration and a rise in their baseline creatinine after
pregnancy than patients with better prepregnancy renal function
[13].
Today, > 15,000 pregnancies have been recorded in > 12,000
kidney transplant recipients worldwide, with a favorable outcome
in 65e92% of the cases [14]. However, few studies have beenby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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has the highest rate of ESRD and dialysis in theworld. In this report,
we describe our experiences in the National Taiwan University
Hospital, Taipei, Taiwan and present a retrospective study for the
period 1992e2013.
Material and methods
Records for patients who had undergone kidney trans-
plantations at the National Taiwan University Hospital were
retrospectively reviewed between January 1, 1992 and December
31, 2013. We used the Electronic Medical Record system at the
National Taiwan University Hospital, and patients with Interna-
tional Classiﬁcation of Diseases codes of “V22: normal pregnancy”
and “V42.0 kidney replaced by transplant” were searched between
January 1, 1992 and December 31, 2013. Women who became
pregnant before kidney transplantation or ongoing dialysis were
excluded. Women who had undergone kidney transplantation and
who became pregnant without follow-up until delivery were also
excluded.
The medical records were reviewed including: maternal age at
delivery, parity, duration between transplantation and pregnancy,
serum creatinine level, birth body weight, gestational age, the
percentile of body weight, and Apgar scores at the 1st minute and
5th minute after birth. Maternal and neonatal complications such as
preeclampsia, gestational diabetes, birth complications, small for
gestational age (< 10th percentile), and prematurity were also
collected. The statistical method was calculation of mean and
standard deviation (SD), recorded as mean ± SD.
This study received ethics approval from the Institutional Re-
view Board of National Taiwan University Hospital, (No.
201312107RINA) on January 29, 2014.
Results
Eighteen pregnancies in 16 women who had undergone kidney
transplantation between January 1, 1992 and December 31, 2013
were included in this study. All of the pregnancies were conceived
naturally. Two of the women decided to terminate their pregnan-
cies. One decision arose from the concern of the use of immuno-
suppressant as well as economic issues. The other resulted from
maternal prior history of hypoxic encephalopathy in the patient,
complicated by mental retardation (IQ ¼ 75). In addition, another
case was excluded as a result of right tubal ectopic pregnancy. AfterTable 1
Maternal transplantation related data.
Patient Underlying disease Type of dialysis Age at Transplantatio
1 RPGN HD 28
2 CGN HD 30
3-1 CGN HD 33
3-2
4-1 SLE HD 30
4-2
5 CGN HD 23
6 CGN HD 16
7 CGN PD 21
8 SLE HD 30
9 CGN PD 36
10 CGN HD 30
11 IgA nephropathy HD 30
12 CGN HD 30
13 CGN HD 26
Mean HD:PD ¼ 11:2 28.5 ± 4.8
CGN ¼ chronic glomerulonephritis; CyA ¼ cyclosporine; HD ¼ hemodialysis; MMF ¼myc
progressive glomerulonephritis; Sir ¼ sirolimus; SLE ¼ systemic lupus erythematosus; Texclusion, the study comprised 15 pregnancies in 13 women who
underwent kidney transplantation in our hospital.
A total of 271 childbearing-age (range,18e49 years) women had
undergone kidney transplantation in our hospital for the period
1992e2013. The fertility rate was approximately 6.6%, without any
artiﬁcial reproductive technologies. Furthermore, two patients
experienced perinatal deaths. The overall rate of successful preg-
nancies was 5.5% for each childbearing age (range, 18e49 years)
woman after kidney transplantation.
The maternal background data is summarized in Table 1. The
mean age of the patients at the time of delivery was 33.8 ± 5 years
(range, 21e41 years). The mean age at the time of transplantation
was 28.5 ± 4.5 years (range, 16e36 years). Immunosuppressant
therapy comprised cyclosporine and prednisolone in eight patients,
mycophenolate mofetil, sirolimus and prednisolone in one patient,
cyclosporine andmycophenolate mofetil in one patient, tacrolimus,
sirolimus, and prednisolone in one patient, tacrolimus and pred-
nisolone in two patients, and tacrolimus in two patients.
Tables 2 and 3 summarizes the pregnancy outcomes. The mean
gestational age was 35.4 ± 3 weeks (range, 26.1e38.3 weeks). The
mean birth body weight was 2208.8 ± 678.8 g (range, 524e3308 g).
Forty percent of the neonates were born small for their gestational
ages (< 10th percentile). Preterm deliveries comprised 53.3% (20.0%,
< 34 weeks and 33.3%, 34e37 weeks), and 26.7% of the neonates
needed NICU admission. Sixty percent of the neonates were born
via cesarean sections and the remaining six women underwent
vaginal deliveries.
Table 4 summarizes the maternal complications and graft out-
comes. The mean serum creatinine level prior to pregnancy was
1.15 ± 0.3 mg/dL (range, 0.7e2.5 mg/dL). The prevalence rate of
preeclampsia of pregnancy was 26.7% (n ¼ 4). The maternal
gestational diabetic rate was 13.3% (n ¼ 2). None of the patients
died during pregnancy or delivery. The graft survival rates at 1-, 5-,
and 10-years after delivery were 100%, 100%, and 92.3%, respec-
tively. Only one woman experienced graft failure at 7 years post-
delivery. In Case 2, graft failure was noted 7 years later, which
resulted from chronic rejection proved by kidney biopsy.
Several unfavorable cases were noted in our study, including
two perinatal mortalities and one neonatal morbidity. In Case 3-1,
the patient received an emergent cesarean section due to previous
cesarean section and fetal distress at gestational age (GA)
35 þ 4 weeks. The initial Apgar score was 0->0->3 and the birth
body weight was 1698 g. Intubation was performed, but the
neonate nevertheless expired due to respiratory failure on the samen Immunosuppressant Duration from transplantation to pregnancy
CyA þ Pred 3 y 2 mo
CyA þ Pred 1 y 3 mo
CyA þ Pred 3 y 10 mo
CyA þ Pred 6 y 5 mo
CyA þ Pred 1 y 11 mo
CyA þ Pred 3 y 7 mo
MMF þ Sir þ Pred 2 y 5 mo
CyA þ MMF 4 y 8 mo
CyA þ Pred 11 y 4 mo
Tac þ Sir þ Pred 2 y 3 mo
CyA þ Pred 3 y 10 mo
Tac þ Pred 1 y 11 mo
Tac 9 y 1 mo
Tac 4 y 7 mo
Tac þ Pred 11 y 1 mo
4 y 6 mo
ophenolate mofetil; PD ¼ peritoneal dialysis; Pred ¼ prednisolone; RPGN ¼ rapidly
ac ¼ tacrolimus.
Table 2
Pregnancy outcomes.
Patient Age at
delivery (y)
History of pregnancy
during hemodialysis
History of pregnancy
after transplantation
Sex Gestational
age (wk)
Birth weight (g) Birth weight
percentile
Apgar score
(1st min)
Apgar score
(5th min)
1 31 G0P0 G2P0SA1 F 36þ6 2276 5.20 8 9
2 32 G0P0 G1P0 F 38þ3 3308 61.80 9 9
3-1 36 G2P1AA1 G3P1AA1 F 35þ4 1698 < 5 0 0
3-2 40 G4P2AA1 M 36þ0 2438 22.90 8 9
4-1 32 G0P0 G1P0 F 34þ5 2080 17.60 7 9
4-2 33 G2P1 F 37þ0 1948 < 5 8 9
5 26 G0P0 G3P0SA1AA1 M 37þ0 2150 < 5 6 8
6 21 G0P0 G1P0 M 36þ1 2368 17.70 8 9
7 37 G0P0 G1P0 M 37þ0 2488 12.20 9 9
8 31 G0P0 G1P0 M 26þ1 524 < 5 0 0
9 41 G0P0 G1P0 M 37þ5 2549 8.10 9 9
10 32 G0P0 G2P0AA1 M 36þ3 3136 76.30 9 9
11 39 G0P0 G1P0 M 32þ3 2062 75 6 8
12 38 G1P1 G2P1 M 37þ5 2800 22.60 9 9
13 38 G0P0 G3P0SA1AA1 F 31þ3 1307 6.60 3 7
Mean 33.8 ± 5 M:F ¼ 6:9 35.4 ± 3 2208.8 ± 678.8 6.6 7.5
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duced a favorable outcome, with a birth body weight of 2438 g at
GA 36 weeks.
In Case 8, the woman was a victim of systemic lupus erythe-
matosus, and her renal function during pregnancy did not deteri-
orate, with serum creatinine 1.1 mg/dL. This woman received
kidney transplantation from a cadaveric donor, using tacrolimus,
sirolimus, and prednisolone as immunosuppressants. Neither pre-
eclampsia nor evidence of systemic lupus erythematosus ﬂare up
was noted. However, reversed end diastolic velocity was noted
during prenatal examination at GA 26 weeks. Emergent delivery
was suggested, but the patient and her family hesitated. Intra-
uterine fetal demise was found 2 days later.
In Case 5, the woman received kidney transplantation from a
related living donor, using mycophenolate mofetil, sirolimus, and
prednisolone as immunosuppressants. The fetus was adequate for
the gestational age prior to GA 29 weeks. However, intrauterine
growth restriction and oligohydramnios was noted starting GA
32 weeks. Prenatal obstetric ultrasound showed no other obvious
fetal anomaly, and no maternal fever or other signs of infection
were noted. After birth, pediatrics brain echo showed generalized
megacystic brain lesionwith calciﬁcation. Bilateral elbow and ankle
arthrogryposis and coarctation of aorta were also noted. CongenitalTable 3
Perinatal morbidities.
Patient Mode of delivery Reasons for cesarean delivery SGA
(< 10%)
P
(<
1 NSD e þ e
2 C/S Cephalopelvic disproportion e e
3-1 C/S Fetal distress & previous C/S þ e
3-2 C/S Previous C/S e e
4-1 C/S Severe preeclampsia e e
4-2 C/S Severe preeclampsia þ e
5 NSD e þ e
6 C/S Cephalopelvic disproportion e e
7 C/S Induction failure e e
8 NSD e þ þ
9 C/S Induction failure e e
10 Vacuum assist e e e
11 C/S Severe preeclampsia e þ
12 NSD e e e
13 NSD e þ þ
Rate (%) NSD: 40 C/S: 60 40.0 2
C/S ¼ cesarean section; IUFD ¼ intrauterine fetal demise; NICU ¼ neonatal intensive care
SGA ¼ small for gestational age.infection was highly suspected by the pediatrics, but the Toxo-
plasmosis, Other (syphilis, varicella-zoster, parvovirus B19),
Rubella, Cytomegalovirus (CMV), and Herpes (TORCH) study yiel-
ded all negative results. Furthermore, failure to thrive and cerebral
palsy were diagnosed at 5 months of age.
Discussion
In this study, the live birth rate was 87%, which is slightly higher
than the one in the meta-analysis reported by Deshpande et al [10]
(78.3%). The most common obstetric complication found in our
study is cesarean section, reported at 60%, which is equal to the rate
reported by Deshpande et al [10] (60%). The rate of preterm delivery
is 53.3%, which is higher than the rate reported by Deshpande et al
[10] (44.8%). Furthermore, the mean gestational age is 35.4 weeks,
which is similar to the outcomes reported by Wyld et al [16]
(35.4 weeks), the most recent report using data from the
Australia and New Zealand Dialysis and Transplant Registry. The
mean birth body weight in our study is 2208 g, smaller than the
outcomes reported by Wyld et al [16] (2485 g).
The data from our center in Taiwan are consistent with those
reported in previous studies of single center experiences world-
wide. As shown in Table 5, mean birth bodyweights and gestationalreterm
34 wk)
Preterm (34e37 wk) NICU admission Other complication
þ e e
e e e
þ þ Fetal death
þ e e
þ e e
e e e
e þ Cerebral palsy
þ e e
e e e
e e REDV, IUFD
e e e
e e e
e þ e
e e e
e þ e
0.0 33.3 26.7
unit; NSD ¼ normal spontaneous delivery; REDV ¼ reversed end diastolic velocity;
Table 4
Graft outcome.
Patient Hypertension
prior to pregnancy
Proteinuria prior
to pregnancy
Preeclampsia Gestational
diabetes
Serum creatinine prior
to pregnancy (mg/dL)
Postpartum serum
creatinine (1 mo)
Postpartum serum
creatinine (6 mo)
Graft
loss
Further maternal
mortality
1 e e e e 0.9 1 1.1 e Lymphoma (at 34 y)
2 e ± e e 1.3 1.4 1.9 þ Graft failure, Sepsis
(at 39 y)
3.1 e þ e e 1.2 1.4 1.4 e Gastric cancer
(at 57 y)3.2 e þ e e 1.9 2.2 2.3
4.1 e e þ e 0.7 0.7 0.9 e e
4.2 e e þ e 0.8 0.8 0.9
5 e ± e e 1 1.2 1 e e
6 e e e e 1.1 1.2 0.8 e e
7 e e e e 1 1.1 2.7 e e
8 e ± e e 1.1 1 1.1 e e
9 þ e þ þ 1 0.9 0.9 e e
10 e e e e 1.1 1.2 1.0 e e
11 þ þ þ þ 0.9 1.1 1.1 e e
12 e e e e 0.8 0.9 0.9 e e
13 e e e e 2.5 2 2.2 e e
Rate (%) 13.3 20.0 26.7 13.3 6.7
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2631 g and from 34.4 weeks to 37.1 weeks, respectively. Cesarean
rates were generally high, ranging from 27.3% to 100%. Pre-
eclampsia rate were also fairly high, ranging from 18.1% to 38.1%.
The gestational diabetes rate was 13.3% in our study, while the
other studies either did not report a rate or reported a rate of 0%.
As for graft and patient survival, previous studies reported that
pregnancy in women with a functioning graft does not have an
adverse impact on patient survival and does not affect long-term
graft survival [8,9,17]. In our study, none of the patients died dur-
ing pregnancy or delivery and the graft survival rates at 5 years
after delivery were 100%.
However, particular attention should be paid to obstetric com-
plications such as hypertension, preeclampsia, gestational diabetes,
as well as delivery outcomes such as cesarean section rates and
preterm deliveries [10].
Current recommendations for pregnancy after kidney trans-
plantation included: (1) a waiting period of at least 1 year for pa-
tients who received a kidney from a living related donor and 2 years
for those who received a kidney from a living nonrelated donor; (2)
serum creatinine< 177mmol/L (< 2mg/dL), preferably<133mmol/
L (< 1.5 mg/dL), with no recent episodes of acute rejection or evi-
dence of ongoing rejection; (3) normal blood pressure or with
minimal hypertensive treatment (a single drug); (4) absence of or
minimal proteinuria (< 0.5 g/d); (5) normal renal ultrasoundTable 5
Comparison between Taiwan and single center experience worldwide.
Parameter Japan South Korea
Period 1977e2002 1991e2005
Number of patients 20 48
Number of pregnancies 29 74
Live birth rate 79% 66%
Mean maternal age 32.1 31.6
Mean gestational age (wk) 35.4 37.1
Mean birth body weight (g) 2229 2631
Premature birth rate (%) 57.10 45.00
Low birth body weight (%) 15 NA
Cesarean section (%) 40.00 39.00
Gestational diabetes (%) NA 0
Preeclampsia (%) 38.10 19.00
Chronic hypertension (%) 25.00 49.00
Reference [15] [18]
NA ¼ not available; NTUH ¼ National Taiwan University Hospital.without pyelocaliceal dilatation; and (6) a low dose of immuno-
suppressive drugs (prednisone<15mg/d, azathioprine<2mg/kg/d,
cyclosporine < 4 mg/kg/d, and tacrolimus at a therapeutic dose),
withdrawal of mycophenolate mofetil and sirolimus [18e21].
A recent review by Wyld et al [16] described the usage of
immunosuppressant regimens over the past 30 years. Before 1990,
most women used a combination of azathioprine and prednisone
as an immunosuppressant, then, from 1991 to 2000, most women
used cyclosporine A-based regimens. Since 2001, 54% of women
have used cyclosporine A-based regimens and 35% of women have
used tacrolimus-based regimens. Although it was still under debate
[22], azathioprine was used less because it was reported to increase
the risk of congenital malformations, speciﬁcally ventricular/atrial
septal defect [23,24], and it was assigned to FDA pregnancy cate-
gory D.
Two patients in our study (Cases 5 and 8) received mycophe-
nolate mofetil and sirolimus as immunosuppressants. They both
experienced poor pregnancy outcomes. Mycophenolate mofetil
was FDA pregnancy category C before and was then reassigned to
pregnancy category D in 2008. A previous study reported that the
use of mycophenolate mofetil during pregnancy was associated
with an increased risk of malformations and ﬁrst trimester preg-
nancy loss [25]. As for sirolimus, its use was reported to be asso-
ciated with two birth defects in nine live births in the National
Transplantation Pregnancy Registry [26], and it was assigned toUSA Italy Mexico NTUH
1993-2002 1997e2010 1990e2005 1992e2013
19 12 60 15
13 13 75 13
NA NA NA 87%
32.2 33.9 26.97 33.8
34.4 35.4 37.1 35.4
2373 2350 2439 2208
45.40 30.00 13.30 53.3
24 15 7.70 40.0
27.30 100 71.30 60.0
NA 0 0 13.3
18.10 33.30 NA 26.7
NA NA NA 13.3
[30] [31] [32]
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different conclusion that the outcomes of pregnancies in women
treated with mycophenolic acid products were similar to the out-
comes in the general population in the National Transplantation
Pregnancy Registry.
As mentioned earlier, Taiwan has the highest rate of ESRD and
dialysis in the world [2]. Chou et al [28] reviewed the pregnancy
outcomes for patients on chronic dialysis in Taiwan, and the overall
rate of successful delivery was 57.1% among women on chronic
hemodialysis, with a mean gestational age of 30.8 ± 1.6 weeks with
a mean birth body weight of 1511 ± 284 g. Comparison of those
ﬁndings with the results of the current study indicate that the
gestational age and birth body weight means for pregnancies in
post kidney transplant women are better. In Japan, Toma et al [29]
documented a signiﬁcant difference in the ratio of live births at 49%
and 82%, respectively. These ﬁndings suggest that when patients
with renal failure wish to become pregnant, a higher chance of
favorable results can be expected if pregnancy is delayed until after
kidney transplantation [15].
Conclusion
The pregnancy outcomes after kidney transplantation were
favorable and the mean birth body weight was 2208.8 ± 678.8 g at
35.4 weeks ± 3.2 weeks gestational age. However, the maternal and
neonatal complication rates were still high, such as preterm labor,
preeclampsia, and small for gestational age.
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